Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide

Saved in:
Bibliographic Details
Published inLeukemia research Vol. 35; no. 5; pp. e41 - e43
Main Authors Dasanu, Constantin A, Schwartz, Robert A, Bauer, Frank, Davis, Lynn K, Silver, Joel S, Reale, Michael A
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.05.2011
Subjects
Aged
Antineoplastic Agents - therapeutic use
Chromosome Deletion
Chromosomes, Human, Pair 5 - genetics
del(5q)
Disease Progression
Drug Resistance, Neoplasm - genetics
Drug Resistance, Neoplasm - physiology
Female
Hematology, Oncology and Palliative Medicine
Humans
Hyperleukocytosis
Lenalidomide
Myelodysplastic syndrome
Myeloproliferative Disorders - complications
Myeloproliferative Disorders - drug therapy
Myeloproliferative Disorders - genetics
Myeloproliferative Disorders - pathology
Myeloproliferative neoplasm
Neoplasms - drug therapy
Neoplasms - genetics
Neoplasms - pathology
Philadelphia Chromosome
Polycythemia vera
Polycythemia Vera - diagnosis
Polycythemia Vera - genetics
Polycythemia Vera - pathology
Splenomegaly - complications
Splenomegaly - pathology
Thalidomide - analogs & derivatives
Thalidomide - therapeutic use
Polycythemia vera
Lenalidomide
Hyperleukocytosis
del(5q)
Myeloproliferative neoplasm
Myelodysplastic syndrome
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2011.01.005